Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Verastem (VSTM) over the last 6 years, with Q3 2025 value amounting to -$37000.0.

  • Verastem's Non Operating Income rose 5194.81% to -$37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$179000.0, marking a year-over-year decrease of 2430.56%. This contributed to the annual value of -$123000.0 for FY2024, which is 1284.4% down from last year.
  • Latest data reveals that Verastem reported Non Operating Income of -$37000.0 as of Q3 2025, which was up 5194.81% from -$110000.0 recorded in Q2 2025.
  • Over the past 5 years, Verastem's Non Operating Income peaked at $28000.0 during Q1 2022, and registered a low of -$110000.0 during Q2 2025.
  • For the 4-year period, Verastem's Non Operating Income averaged around -$23071.4, with its median value being -$18500.0 (2023).
  • As far as peak fluctuations go, Verastem's Non Operating Income crashed by 76666.67% in 2023, and later soared by 5194.81% in 2025.
  • Over the past 4 years, Verastem's Non Operating Income (Quarter) stood at -$7000.0 in 2022, then plummeted by 85.71% to -$13000.0 in 2023, then surged by 161.54% to $8000.0 in 2024, then crashed by 562.5% to -$37000.0 in 2025.
  • Its last three reported values are -$37000.0 in Q3 2025, -$110000.0 for Q2 2025, and -$40000.0 during Q1 2025.